Advanced Oncotherapy (FRA:R3I1) Cash And Cash Equivalents : €2.92 Mil (As of Jun. 2022)

View and export this data going back to 2018. Start your Free Trial

What is Advanced Oncotherapy Cash And Cash Equivalents?

Advanced Oncotherapy's quarterly cash and cash equivalents increased from Jun. 2021 (€0.84 Mil) to Dec. 2021 (€4.43 Mil) but then stayed the same from Dec. 2021 (€4.43 Mil) to Jun. 2022 (€2.92 Mil).

Advanced Oncotherapy's annual cash and cash equivalents declined from Dec. 2019 (€3.23 Mil) to Dec. 2020 (€2.01 Mil) but then increased from Dec. 2020 (€2.01 Mil) to Dec. 2021 (€4.43 Mil).

Advanced Oncotherapy Cash And Cash Equivalents Historical Data

The historical data trend for Advanced Oncotherapy's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Advanced Oncotherapy Cash And Cash Equivalents Chart

Advanced Oncotherapy Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Cash And Cash Equivalents

Get a 7-Day Free Trial

0.06

1.13

3.23

2.01

4.43

Advanced Oncotherapy Semi-Annual Data
	Dec12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22
Cash And Cash Equivalents	Get a 7-Day Free Trial															6.39	2.01	0.84	4.43	2.92

Advanced Oncotherapy Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Advanced Oncotherapy (FRA:R3I1) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Advanced Oncotherapy Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Advanced Oncotherapy's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Advanced Oncotherapy (FRA:R3I1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Advanced Oncotherapy PLC (FRA:R3I1) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

N/A

Address

4 Tenterden Street, Third Floor, London, GBR, W1S 1TE

Website

https://www.avoplc.com

Advanced Oncotherapy PLC is active in the healthcare domain in the United Kingdom. As a medical care provider, its focus is to develop technologies to maximize the destructive effect of radiation on tumors whilst minimizing damage to healthy tissues. It develops an affordable proton-based radiotherapy system, using innovative and clinically effective technology, thereby contributing to curing critical unmet conditions. The company's only business segment is Proton Therapy.

Advanced Oncotherapy (FRA:R3I1) Headlines

No Headlines